Molecular definition of breast tumor heterogeneity. [Cancer Cell. 2007] - PubMed

Save items

loading

Related citations in PubMed

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. [Hum Pathol. 2012]
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH. Hum Pathol. 2012 Mar; 43(3):364-73. Epub 2011 Aug 10.
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. [PLoS One. 2009]
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al. PLoS One. 2009 Dec 21; 4(12):e8377. Epub 2009 Dec 21.
Review Mammary stem cells and breast cancer--role of Notch signalling. [Stem Cell Rev. 2007]
Review Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G, Clarke RB. Stem Cell Rev. 2007 Jun; 3(2):169-75.
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. [J Clin Pathol. 2011]
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J. J Clin Pathol. 2011 Nov; 64(11):937-46. Epub 2011 Jun 16.
Review Breast cancer stem cells and intrinsic subtypes: controversies rage on. [Curr Stem Cell Res Ther. 2009]
Review Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H, Srour EF, Badve S. Curr Stem Cell Res Ther. 2009 Jan; 4(1):50-60.

See reviews... See all...

Cited by over 100 PubMed Central articles

Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. [Proc Natl Acad Sci U S A. 2012]
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H, et al. Proc Natl Acad Sci U S A. 2012 Apr 17; 109(16):6124-9. Epub 2012 Mar 27.
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. [Int J Mol Sci. 2012]
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.
Diaz-Cano SJ. Int J Mol Sci. 2012; 13(2):1951-2011. Epub 2012 Feb 13.
Prostate cancer stem cell biology. [Minerva Urol Nefrol. 2012]
Prostate cancer stem cell biology.
Yu C, Yao Z, Jiang Y, Keller ET. Minerva Urol Nefrol. 2012 Mar; 64(1):19-33.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Molecular definition of breast tumor heterogeneity.
Molecular definition of breast tumor heterogeneity.
Cancer Cell. 2007 Mar ;11(3):259-73.

PubMed
Imaging mass spectrometry: principles and potentials.
Imaging mass spectrometry: principles and potentials.
Toxicol Pathol. 2005 ;33(1):92-101.

PubMed
Breast cancer and hormone-replacement therapy in the Million Women Study.
Breast cancer and hormone-replacement therapy in the Million Women Study.
Lancet. 2003 Aug 9 ;362(9382):419-27.

PubMed
Thyroid and other autoantibodies in British and Japanese women: an epidemiologic...
Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer.
Br Med J. 1976 Jan 31 ;1(6004):257-9.

PubMed
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to...
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.
Proc Natl Acad Sci U S A. 2000 May 23 ;97(11):5768-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Molecular definition of breast tumor heterogeneity.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by over 100 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information